MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Jinho JungRohan R LoombaKento ImajoEgbert MadambaSanil GandhiRicki BettencourtSeema SinghCarolyn HernandezMark A ValasekCynthia BehlingLisa RichardsKatie FowlerClaude B SirlinHirokazu TakahashiStephen CaldwellPublished in: Gut (2020)
MRE combined with FIB-4 (MEFIB) index may be used for non-invasive identification of candidates for (≥stage 2 fibrosis) pharmacological therapy among patients with NAFLD with a high PPV.